Aclaris Therapeutics, Inc. 4
4 · Aclaris Therapeutics, Inc. · Filed Jul 1, 2016
Insider Transaction Report
Form 4
Bierly Rick
Director
Transactions
- Award
Stock Option (right to buy)
2016-06-29+6,632→ 6,632 totalExercise: $18.32Exp: 2026-06-28→ Common Stock (6,632 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in twelve equal monthly installments through June 29, 2017, subject to the reporting person's continuous service as of such vesting date.